{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T00:03:09Z","timestamp":1774310589548,"version":"3.50.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:00:00Z","timestamp":1772755200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"vor","delay-in-days":17,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Nantong Municipal Science and Technology Project","award":["JC2023033"],"award-info":[{"award-number":["JC2023033"]}]},{"name":"Nantong Natural Science Foundation and scientific research special project of Nantong Health Commission","award":["No. MS2022059"],"award-info":[{"award-number":["No. MS2022059"]}]},{"name":"Startup Fund for scientific research, Fujian Medical University","award":["2022QH1259"],"award-info":[{"award-number":["2022QH1259"]}]},{"name":"Science and Technology Project of Quanzhou","award":["2024QZC004YR"],"award-info":[{"award-number":["2024QZC004YR"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-29391-7","type":"journal-article","created":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T10:16:41Z","timestamp":1772792201000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Functional genomics integration of glycolysis-related gene networks reveals prognostic biomarkers and immune microenvironment regulation in breast cancer"],"prefix":"10.1038","volume":"16","author":[{"given":"Yingjie","family":"Niu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhitang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,6]]},"reference":[{"key":"29391_CR1","doi-asserted-by":"publisher","first-page":"9347","DOI":"10.1038\/s41598-025-93883-9","volume":"15","author":"Y Cai","year":"2025","unstructured":"Cai, Y., Dai, F., Ye, Y. & Qian, J. The global burden of breast cancer among women of reproductive age: a comprehensive analysis. Sci. Rep. 15, 9347. https:\/\/doi.org\/10.1038\/s41598-025-93883-9 (2025).","journal-title":"Sci. Rep."},{"key":"29391_CR2","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray, F. et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 74, 229\u2013263. https:\/\/doi.org\/10.3322\/caac.21834 (2024).","journal-title":"CA Cancer J. Clin."},{"key":"29391_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-02108-4","author":"X Xiong","year":"2025","unstructured":"Xiong, X. et al. Breast cancer: pathogenesis and treatments. Signal. Transduct. Target. Ther. https:\/\/doi.org\/10.1038\/s41392-024-02108-4 (2025).","journal-title":"Signal. Transduct. Target. Ther."},{"key":"29391_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17071102","author":"E Carvalho","year":"2025","unstructured":"Carvalho, E., Canberk, S., Schmitt, F. & Vale, N. Molecular subtypes and mechanisms of breast cancer: precision medicine approaches for targeted therapies. Cancers (Basel) https:\/\/doi.org\/10.3390\/cancers17071102 (2025).","journal-title":"Cancers (Basel)"},{"key":"29391_CR5","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.cell.2016.12.039","volume":"168","author":"MG Vander Heiden","year":"2017","unstructured":"Vander Heiden, M. G. & DeBerardinis, R. J. Understanding the intersections between metabolism and cancer biology. Cell 168, 657\u2013669. https:\/\/doi.org\/10.1016\/j.cell.2016.12.039 (2017).","journal-title":"Cell"},{"key":"29391_CR6","doi-asserted-by":"publisher","first-page":"99","DOI":"10.31083\/j.fbl2903099","volume":"29","author":"E Mitaishvili","year":"2024","unstructured":"Mitaishvili, E. et al. The molecular mechanisms behind advanced breast cancer metabolism: Warburg Effect, OXPHOS, and calcium. Front. Biosci. (Landmark Ed). 29, 99. https:\/\/doi.org\/10.31083\/j.fbl2903099 (2024).","journal-title":"Front. Biosci. (Landmark Ed)"},{"key":"29391_CR7","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s12943-023-01841-8","volume":"22","author":"SW Yue","year":"2023","unstructured":"Yue, S. W. et al. m6A-regulated tumor glycolysis: new advances in epigenetics and metabolism. Mol. Cancer. 22, 137. https:\/\/doi.org\/10.1186\/s12943-023-01841-8 (2023).","journal-title":"Mol. Cancer"},{"key":"29391_CR8","doi-asserted-by":"publisher","first-page":"698023","DOI":"10.3389\/fonc.2021.698023","volume":"11","author":"C Liu","year":"2021","unstructured":"Liu, C., Jin, Y. & Fan, Z. The mechanism of Warburg Effect-Induced chemoresistance in cancer. Front. Oncol. 11, 698023. https:\/\/doi.org\/10.3389\/fonc.2021.698023 (2021).","journal-title":"Front. Oncol."},{"key":"29391_CR9","doi-asserted-by":"publisher","first-page":"393","DOI":"10.3233\/CBM-210446","volume":"34","author":"J Zou","year":"2022","unstructured":"Zou, J., Gu, Y., Zhu, Q., Li, X. & Qin, L. Identifying glycolysis-related LncRNAs for predicting prognosis in breast cancer patients. Cancer Biomark. 34, 393\u2013401. https:\/\/doi.org\/10.3233\/CBM-210446 (2022).","journal-title":"Cancer Biomark."},{"key":"29391_CR10","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/s41423-021-00727-3","volume":"19","author":"BI Reinfeld","year":"2022","unstructured":"Reinfeld, B. I., Rathmell, W. K., Kim, T. K. & Rathmell, J. C. The therapeutic implications of immunosuppressive tumor aerobic Glycolysis. Cell. Mol. Immunol. 19, 46\u201358. https:\/\/doi.org\/10.1038\/s41423-021-00727-3 (2022).","journal-title":"Cell. Mol. Immunol."},{"key":"29391_CR11","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/j.jgg.2023.05.003","volume":"50","author":"J Zhang","year":"2023","unstructured":"Zhang, J. & Zhao, H. eQTL studies: from bulk tissues to single cells. J. Genet. Genomics. 50, 925\u2013933. https:\/\/doi.org\/10.1016\/j.jgg.2023.05.003 (2023).","journal-title":"J. Genet. Genomics"},{"key":"29391_CR12","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1038\/s41467-018-03133-y","volume":"9","author":"L Gao","year":"2018","unstructured":"Gao, L. et al. Identifying noncoding risk variants using disease-relevant gene regulatory networks. Nat. Commun. 9, 702. https:\/\/doi.org\/10.1038\/s41467-018-03133-y (2018).","journal-title":"Nat. Commun."},{"key":"29391_CR13","doi-asserted-by":"publisher","first-page":"13924","DOI":"10.1073\/pnas.1402665111","volume":"111","author":"J Fadista","year":"2014","unstructured":"Fadista, J. et al. Global genomic and transcriptomic analysis of human pancreatic Islets reveals novel genes influencing glucose metabolism. Proc. Natl. Acad. Sci. U S A. 111, 13924\u201313929. https:\/\/doi.org\/10.1073\/pnas.1402665111 (2014).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"29391_CR14","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1182\/blood-2017-03-774422","volume":"130","author":"L Rasche","year":"2017","unstructured":"Rasche, L. et al. Low expression of hexokinase-2 is associated with false-negative FDG-positron emission tomography in multiple myeloma. Blood 130, 30\u201334. https:\/\/doi.org\/10.1182\/blood-2017-03-774422 (2017).","journal-title":"Blood"},{"key":"29391_CR15","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.21037\/tlcr-22-34","volume":"11","author":"Y Feng","year":"2022","unstructured":"Feng, Y. et al. Causal effects of genetically determined metabolites on cancers included lung, breast, ovarian cancer, and glioma: a Mendelian randomization study. Transl Lung Cancer Res. 11, 1302\u20131314. https:\/\/doi.org\/10.21037\/tlcr-22-34 (2022).","journal-title":"Transl Lung Cancer Res."},{"key":"29391_CR16","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1186\/s12885-024-12515-z","volume":"24","author":"R Huang","year":"2024","unstructured":"Huang, R. et al. Genetically evaluating the causal role of peripheral immune cells in colorectal cancer: a two-sample Mendelian randomization study. BMC Cancer. 24, 753. https:\/\/doi.org\/10.1186\/s12885-024-12515-z (2024).","journal-title":"BMC Cancer"},{"key":"29391_CR17","doi-asserted-by":"publisher","first-page":"105389","DOI":"10.1016\/j.ebiom.2024.105389","volume":"109","author":"Z Zhou","year":"2024","unstructured":"Zhou, Z. et al. Single cell atlas reveals multilayered metabolic heterogeneity across tumour types. EBioMedicine 109, 105389. https:\/\/doi.org\/10.1016\/j.ebiom.2024.105389 (2024).","journal-title":"EBioMedicine"},{"key":"29391_CR18","doi-asserted-by":"publisher","first-page":"1427626","DOI":"10.3389\/fimmu.2024.1427626","volume":"15","author":"X Wu","year":"2024","unstructured":"Wu, X. et al. Identification and validation of glycolysis-related diagnostic signatures in diabetic nephropathy: a study based on integrative machine learning and single-cell sequence. Front. Immunol. 15, 1427626. https:\/\/doi.org\/10.3389\/fimmu.2024.1427626 (2024).","journal-title":"Front. Immunol."},{"key":"29391_CR19","doi-asserted-by":"publisher","first-page":"D672","DOI":"10.1093\/nar\/gkae909","volume":"53","author":"M Kanehisa","year":"2025","unstructured":"Kanehisa, M., Furumichi, M., Sato, Y., Matsuura, Y. & Ishiguro-Watanabe, M. KEGG: biological systems database as a model of the real world. Nucleic Acids Res. 53, D672\u2013D677. https:\/\/doi.org\/10.1093\/nar\/gkae909 (2025).","journal-title":"Nucleic Acids Res."},{"key":"29391_CR20","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1002\/pro.3715","volume":"28","author":"M Kanehisa","year":"2019","unstructured":"Kanehisa, M. Toward Understanding the origin and evolution of cellular organisms. Protein Sci. 28, 1947\u20131951. https:\/\/doi.org\/10.1002\/pro.3715 (2019).","journal-title":"Protein Sci."},{"key":"29391_CR21","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28, 27\u201330 (2000).","journal-title":"Nucleic Acids Res."},{"key":"29391_CR22","doi-asserted-by":"publisher","first-page":"142113","DOI":"10.1016\/j.ijbiomac.2025.142113","volume":"307","author":"Z Tang","year":"2025","unstructured":"Tang, Z. et al. Integrated analysis of multiple programmed cell death-related prognostic genes and functional validation of apoptosis-related genes in osteosarcoma. Int. J. Biol. Macromol. 307, 142113. https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.142113 (2025).","journal-title":"Int. J. Biol. Macromol."},{"key":"29391_CR23","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1186\/s12935-024-03592-y","volume":"24","author":"M Gao","year":"2024","unstructured":"Gao, M. et al. Machine learning-based prognostic model of lactylation-related genes for predicting prognosis and immune infiltration in patients with lung adenocarcinoma. Cancer Cell. Int. 24, 400. https:\/\/doi.org\/10.1186\/s12935-024-03592-y (2024).","journal-title":"Cancer Cell. Int."},{"key":"29391_CR24","doi-asserted-by":"publisher","first-page":"134629","DOI":"10.1016\/j.ijbiomac.2024.134629","volume":"278","author":"X Li","year":"2024","unstructured":"Li, X. et al. Structure of POU2AF1 Recombinant protein and it affects the progression and treatment of liver cancer based on WGCNA and molecular Docking analysis. Int. J. Biol. Macromol. 278, 134629. https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.134629 (2024).","journal-title":"Int. J. Biol. Macromol."},{"key":"29391_CR25","doi-asserted-by":"publisher","first-page":"103851","DOI":"10.1016\/j.breast.2024.103851","volume":"79","author":"L Liao","year":"2025","unstructured":"Liao, L. Inequality in breast cancer: global statistics from 2022 to 2050. Breast 79, 103851. https:\/\/doi.org\/10.1016\/j.breast.2024.103851 (2025).","journal-title":"Breast"},{"key":"29391_CR26","doi-asserted-by":"publisher","first-page":"2935","DOI":"10.1007\/s12094-024-03541-1","volume":"26","author":"R Colomer","year":"2024","unstructured":"Colomer, R. et al. Biomarkers in breast cancer 2024: an updated consensus statement by the Spanish society of medical oncology and the Spanish society of pathology. Clin. Transl Oncol. 26, 2935\u20132951. https:\/\/doi.org\/10.1007\/s12094-024-03541-1 (2024).","journal-title":"Clin. Transl Oncol."},{"key":"29391_CR27","doi-asserted-by":"publisher","first-page":"101076","DOI":"10.1016\/j.neo.2024.101076","volume":"58","author":"M Cordani","year":"2024","unstructured":"Cordani, M. et al. The role of Glycolysis in tumorigenesis: from biological aspects to therapeutic opportunities. Neoplasia 58, 101076. https:\/\/doi.org\/10.1016\/j.neo.2024.101076 (2024).","journal-title":"Neoplasia"},{"key":"29391_CR28","first-page":"3041","volume":"13","author":"M Oshi","year":"2023","unstructured":"Oshi, M. et al. Accelerated Glycolysis in tumor microenvironment is associated with worse survival in triple-negative but not consistently with ER+\/HER2- breast cancer. Am. J. Cancer Res. 13, 3041\u20133054 (2023).","journal-title":"Am. J. Cancer Res."},{"key":"29391_CR29","doi-asserted-by":"publisher","first-page":"103627","DOI":"10.1016\/j.ebiom.2021.103627","volume":"73","author":"ZH Wang","year":"2021","unstructured":"Wang, Z. H., Peng, W. B., Zhang, P., Yang, X. P. & Zhou, Q. Lactate in the tumour microenvironment: from immune modulation to therapy. EBioMedicine 73, 103627. https:\/\/doi.org\/10.1016\/j.ebiom.2021.103627 (2021).","journal-title":"EBioMedicine"},{"key":"29391_CR30","doi-asserted-by":"publisher","first-page":"118604","DOI":"10.1016\/j.bbamcr.2019.118604","volume":"1867","author":"MB N","year":"2020","unstructured":"N, M. B. et al. Aerobic Glycolysis is a metabolic requirement to maintain the M2-like polarization of tumor-associated macrophages. Biochim. Biophys. Acta Mol. Cell. Res. 1867, 118604. https:\/\/doi.org\/10.1016\/j.bbamcr.2019.118604 (2020).","journal-title":"Biochim. Biophys. Acta Mol. Cell. Res."},{"key":"29391_CR31","doi-asserted-by":"publisher","first-page":"1186383","DOI":"10.3389\/fimmu.2023.1186383","volume":"14","author":"W Li","year":"2023","unstructured":"Li, W. et al. Cell metabolism-based optimization strategy of CAR-T cell function in cancer therapy. Front. Immunol. 14, 1186383. https:\/\/doi.org\/10.3389\/fimmu.2023.1186383 (2023).","journal-title":"Front. Immunol."},{"key":"29391_CR32","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/j.cmet.2018.02.024","volume":"27","author":"T Cascone","year":"2018","unstructured":"Cascone, T. et al. Increased Tumor Glycolysis Characterizes Immune Resistance to Adoptive T Cell Therapy. Cell Metab 27, 977-987.e4. https:\/\/doi.org\/10.1016\/j.cmet.2018.02.024 (2018).","journal-title":"Cell Metab"},{"key":"29391_CR33","doi-asserted-by":"publisher","first-page":"106087","DOI":"10.1016\/j.intimp.2019.106087","volume":"78","author":"V Hashemi","year":"2020","unstructured":"Hashemi, V. et al. Regulatory T cells in breast cancer as a potent anti-cancer therapeutic target. Int. Immunopharmacol. 78, 106087. https:\/\/doi.org\/10.1016\/j.intimp.2019.106087 (2020).","journal-title":"Int. Immunopharmacol."},{"key":"29391_CR34","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s13046-025-03394-8","volume":"44","author":"S Imani","year":"2025","unstructured":"Imani, S. et al. Reprogramming the breast tumor immune microenvironment: cold-to-hot transition for enhanced immunotherapy. J. Exp. Clin. Cancer Res. 44, 131. https:\/\/doi.org\/10.1186\/s13046-025-03394-8 (2025).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"29391_CR35","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1093\/carcin\/bgp289","volume":"31","author":"R Behera","year":"2010","unstructured":"Behera, R., Kumar, V., Lohite, K., Karnik, S. & Kundu, G. C. Activation of JAK2\/STAT3 signaling by osteopontin promotes tumor growth in human breast cancer cells. Carcinogenesis 31, 192\u2013200. https:\/\/doi.org\/10.1093\/carcin\/bgp289 (2010).","journal-title":"Carcinogenesis"},{"key":"29391_CR36","doi-asserted-by":"publisher","first-page":"731751","DOI":"10.3389\/fimmu.2021.731751","volume":"12","author":"Z Wang","year":"2021","unstructured":"Wang, Z. et al. The CXCL family contributes to immunosuppressive microenvironment in gliomas and assists in gliomas chemotherapy. Front. Immunol. 12, 731751. https:\/\/doi.org\/10.3389\/fimmu.2021.731751 (2021).","journal-title":"Front. Immunol."},{"key":"29391_CR37","doi-asserted-by":"publisher","first-page":"106541","DOI":"10.1016\/j.biocel.2024.106541","volume":"169","author":"Y Li","year":"2024","unstructured":"Li, Y. et al. Tumor necrosis factor alpha-induced protein 8-like-2 controls microglia phenotype via metabolic reprogramming in BV2 microglial cells and responses to neuropathic pain. Int. J. Biochem. Cell. Biol. 169, 106541. https:\/\/doi.org\/10.1016\/j.biocel.2024.106541 (2024).","journal-title":"Int. J. Biochem. Cell. Biol."},{"key":"29391_CR38","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1002\/iub.1086","volume":"64","author":"X Zhi","year":"2012","unstructured":"Zhi, X. et al. Potential prognostic biomarker CD73 regulates epidermal growth factor receptor expression in human breast cancer. IUBMB Life. 64, 911\u2013920. https:\/\/doi.org\/10.1002\/iub.1086 (2012).","journal-title":"IUBMB Life"},{"key":"29391_CR39","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1158\/1078-0432.ccr-0811-03","volume":"10","author":"J Spychala","year":"2004","unstructured":"Spychala, J. et al. Role of Estrogen receptor in the regulation of ecto-5\u2019-nucleotidase and adenosine in breast cancer. Clin. Cancer Res. 10, 708\u2013717. https:\/\/doi.org\/10.1158\/1078-0432.ccr-0811-03 (2004).","journal-title":"Clin. Cancer Res."},{"key":"29391_CR40","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.yexcr.2008.08.015","volume":"315","author":"L Pentassuglia","year":"2009","unstructured":"Pentassuglia, L. & Sawyer, D. B. The role of Neuregulin-1beta\/ErbB signaling in the heart. Exp. Cell. Res. 315, 627\u2013637. https:\/\/doi.org\/10.1016\/j.yexcr.2008.08.015 (2009).","journal-title":"Exp. Cell. Res."},{"key":"29391_CR41","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1186\/s12885-021-08318-1","volume":"21","author":"Y Liu","year":"2021","unstructured":"Liu, Y. et al. Highly heterogeneous-related genes of triple-negative breast cancer: potential diagnostic and prognostic biomarkers. BMC Cancer. 21, 644. https:\/\/doi.org\/10.1186\/s12885-021-08318-1 (2021).","journal-title":"BMC Cancer"},{"key":"29391_CR42","doi-asserted-by":"publisher","first-page":"29064","DOI":"10.18632\/oncotarget.25561","volume":"9","author":"P Cancemi","year":"2018","unstructured":"Cancemi, P. et al. A multiomics analysis of S100 protein family in breast cancer. Oncotarget 9, 29064\u201329081. https:\/\/doi.org\/10.18632\/oncotarget.25561 (2018).","journal-title":"Oncotarget"},{"key":"29391_CR43","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.ejso.2007.04.009","volume":"34","author":"I Salama","year":"2008","unstructured":"Salama, I., Malone, P. S., Mihaimeed, F. & Jones, J. L. A review of the S100 proteins in cancer. Eur. J. Surg. Oncol. 34, 357\u2013364. https:\/\/doi.org\/10.1016\/j.ejso.2007.04.009 (2008).","journal-title":"Eur. J. Surg. Oncol."},{"key":"29391_CR44","doi-asserted-by":"publisher","DOI":"10.3390\/molecules22101551","author":"Y Cheng","year":"2017","unstructured":"Cheng, Y. & Tian, H. Current development status of MEK inhibitors. Molecules https:\/\/doi.org\/10.3390\/molecules22101551 (2017).","journal-title":"Molecules"},{"key":"29391_CR45","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1158\/0008-5472.CAN-09-1751","volume":"70","author":"CM Chresta","year":"2010","unstructured":"Chresta, C. M. et al. AZD8055 is a potent, selective, and orally bioavailable ATP-competitive mammalian target of Rapamycin kinase inhibitor with in vitro and in vivo antitumor activity. Cancer Res. 70, 288\u2013298. https:\/\/doi.org\/10.1158\/0008-5472.CAN-09-1751 (2010).","journal-title":"Cancer Res."},{"key":"29391_CR46","doi-asserted-by":"publisher","first-page":"2547","DOI":"10.1038\/onc.2010.626","volume":"30","author":"V Serra","year":"2011","unstructured":"Serra, V. et al. PI3K Inhibition results in enhanced HER signaling and acquired ERK dependency in HER2-overexpressing breast cancer. Oncogene 30, 2547\u20132557. https:\/\/doi.org\/10.1038\/onc.2010.626 (2011).","journal-title":"Oncogene"},{"key":"29391_CR47","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s00432-007-0292-z","volume":"134","author":"L Wang","year":"2008","unstructured":"Wang, L. et al. Ecto-5\u2019-nucleotidase promotes invasion, migration and adhesion of human breast cancer cells. J. Cancer Res. Clin. Oncol. 134, 365\u2013372. https:\/\/doi.org\/10.1007\/s00432-007-0292-z (2008).","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"29391_CR48","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2023-007349","author":"N Babl","year":"2023","unstructured":"Babl, N. et al. MCT4 blockade increases the efficacy of immune checkpoint blockade. J. Immunother Cancer https:\/\/doi.org\/10.1136\/jitc-2023-007349 (2023).","journal-title":"J. Immunother Cancer"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-29391-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-29391-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-29391-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T23:04:18Z","timestamp":1774307058000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-29391-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,6]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["29391"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-29391-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,6]]},"assertion":[{"value":"2 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All patients enrolled in the study signed the consent for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"9583"}}